Drug Profile
Research programme: inflammatory and metabolic pathway modulators - Complexa
Alternative Names: NFA derivatives - Complexa; Nitro fatty-acid derivatives - ComplexaLatest Information Update: 28 Feb 2024
Price :
$50
*
At a glance
- Originator Complexa
- Class Nitro compounds; Small molecules; Unsaturated fatty acids
- Mechanism of Action Inflammation mediator modulators; Transcription factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Fibrosis; Inflammation
- Discontinued Metabolic disorders; Neurodegenerative disorders
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for research development in Fibrosis in USA
- 28 Jan 2022 No recent reports of development identified for research development in Inflammation in USA
- 06 Jan 2020 Early research is ongoing in Inflammation in USA (Complexa pipeline, January 2020)